Application of Nano-Radiosensitizers in Combination Cancer Therapy Publisher



Varzandeh M¹ ; Sabouri L^{2, 3} ; Mansouri V^{3, 4} ; Gharibshahian M^{3, 5} ; Beheshtizadeh N^{3, 6} ; Hamblin MR^{7, 8} ; Rezaei N^{8, 9, 10}
Source: Bioengineering and Translational Medicine Published:2023

Abstract

Radiosensitizers are compounds or nanostructures, which can improve the efficiency of ionizing radiation to kill cells. Radiosensitization increases the susceptibility of cancer cells to radiation-induced killing, while simultaneously reducing the potentially damaging effect on the cellular structure and function of the surrounding healthy tissues. Therefore, radiosensitizers are therapeutic agents used to boost the effectiveness of radiation treatment. The complexity and heterogeneity of cancer, and the multifactorial nature of its pathophysiology has led to many approaches to treatment. The effectiveness of each approach has been proven to some extent, but no definitive treatment to eradicate cancer has been discovered. The current review discusses a broad range of nano-radiosensitizers, summarizing possible combinations of radiosensitizing NPs with several other types of cancer therapy options, focusing on the benefits and drawbacks, challenges, and future prospects. © 2023 The Authors. Bioengineering & Translational Medicine published by Wiley Periodicals LLC on behalf of American Institute of Chemical Engineers.